162 related articles for article (PubMed ID: 24659311)
1. An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.
Rascon J; Rageliene L; Stankeviciene S; Palionis D; Tamosiunas AE; Valeviciene N; Zvirblis T
Eur J Pediatr; 2014 Sep; 173(9):1137-46. PubMed ID: 24659311
[TBL] [Abstract][Full Text] [Related]
2. Iron Overload in Children with Leukemia Receiving Multiple Blood Transfusions.
Nair M; Kuttath V; Nair AR; Rajeswari B; Chellappan G; Thankamony P; Parukkutty K
Indian Pediatr; 2018 Nov; 55(11):962-965. PubMed ID: 30587644
[TBL] [Abstract][Full Text] [Related]
3. Iron Overload in Survivors of Childhood Cancer.
Trovillion EM; Schubert L; Dietz AC
J Pediatr Hematol Oncol; 2018 Jul; 40(5):396-400. PubMed ID: 28562518
[TBL] [Abstract][Full Text] [Related]
4. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
[TBL] [Abstract][Full Text] [Related]
5. Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload.
Panch SR; Yau YY; West K; Diggs K; Sweigart T; Leitman SF
Transfusion; 2015 Mar; 55(3):611-22. PubMed ID: 25209879
[TBL] [Abstract][Full Text] [Related]
6. Number of erythrocyte transfusions is more predictive than serum ferritin in estimation of cardiac iron loading in pediatric patients with acute lymphoblastic leukemia.
Unal S; Cetin M; Hazirolan T; Yildirim G; Meral A; Birbilen A; Karabulut E; Aytac S; Tavil B; Kuskonmaz B; Tuncer M; Gumruk F
Leuk Res; 2014 Aug; 38(8):882-5. PubMed ID: 24933623
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
[TBL] [Abstract][Full Text] [Related]
8. Glycosylated ferritin as an improved marker for post-transfusion iron overload.
Ishihara A; Yamauchi T; Ikeda K; Fukuyoshi Y; Yokoyama T; Yonemura Y; Uchiba M; Matsui H
Int J Hematol; 2021 Apr; 113(4):537-546. PubMed ID: 33400141
[TBL] [Abstract][Full Text] [Related]
9. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
10. Iron overload in children undergoing cancer treatments.
de Ville de Goyet M; Moniotte S; Robert A; Dupont S; Vermylen C; Veyckemans F; Brichard B
Pediatr Blood Cancer; 2013 Dec; 60(12):1982-7. PubMed ID: 23897631
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP).
Files B; Brambilla D; Kutlar A; Miller S; Vichinsky E; Wang W; Granger S; Adams RJ
J Pediatr Hematol Oncol; 2002 May; 24(4):284-90. PubMed ID: 11972097
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional study.
Nolte F; Nückel H; Schmidt B; Geer T; Rubanov O; Hebart H; Jarisch A; Albrecht S; Johr C; Schumann C; Hofmann WK
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1531-1538. PubMed ID: 29761371
[TBL] [Abstract][Full Text] [Related]
13. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
[TBL] [Abstract][Full Text] [Related]
14. Characterization of transfusion-derived iron deposition in childhood cancer survivors.
Ruccione KS; Wood JC; Sposto R; Malvar J; Chen C; Freyer DR
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1913-9. PubMed ID: 24962841
[TBL] [Abstract][Full Text] [Related]
15. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
[TBL] [Abstract][Full Text] [Related]
16. Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
Wilson SR; Sears M; Williams E; Drapekin J; Sivakumar I; Padrino S; Desai PC; Hager W; Manwani D; Clay LJ; Field JJ; Kanter J; Cohen AJ; Saif Ur Rehman S; Lanzkron S; Little JA;
Br J Haematol; 2021 Dec; 195(5):e157-e160. PubMed ID: 34423416
[No Abstract] [Full Text] [Related]
17. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
Pipaliya N; Solanke D; Parikh P; Ingle M; Sharma R; Sharma S; Sawant P
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
[TBL] [Abstract][Full Text] [Related]
18. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and management of iron overload in 631 patients with chronic transfusion dependency: results from a multicentre, observational study.
Cid J; Palomera L; Díaz M; Zamora C; Solano F
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s119-23. PubMed ID: 23522894
[TBL] [Abstract][Full Text] [Related]
20. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
Goto T; Ikuta K; Inamoto Y; Kamoshita S; Yokohata E; Koyama D; Onodera K; Seto A; Watanabe K; Imahashi N; Tsukamoto S; Ozawa Y; Sasaki K; Ito M; Kohgo Y; Miyamura K
Int J Hematol; 2013 Jan; 97(1):125-34. PubMed ID: 23264147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
